Global mRNA Extraction And Purification Market By Product Type
Global mRNA Extraction And Purification Market By Method Type
Global mRNA Extraction And Purification Market By Application
Global mRNA Extraction And Purification Market By End-Users,
Global mRNA Extraction And Purification Market By Region,
North America mRNA Extraction And Purification Market, by Country
Europe mRNA Extraction And Purification Market, by Country
Asia Pacific mRNA Extraction And Purification Market, by Country
Latin America mRNA Extraction And Purification Market, by Country
Middle East & Africa mRNA Extraction And Purification Market, by Country
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global MRNA Synthesis Raw Materials Market Snapshot
Chapter 4. Global MRNA Synthesis Raw Materials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2034-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
5.2.1. Kits
5.2.2. Reagents
5.2.3. Instruments
Chapter 6. Market Segmentation 2: By Method Type Estimates & Trend Analysis
6.1. By Method Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Method Type:
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. Chromatography
6.2.2.1. Affinity
6.2.2.2. OligodT Chromatography Resins
6.2.2.3. Others
6.2.2.4. Ion Exchange
6.2.2.5. Hydrophobic Interaction
6.2.2.6. Others (Multimodal, Reverse Phase, etc.)
6.2.3. Oligo Deoxythymidine (dT) Magnetic Particles
6.2.4. Lithium Chloride Precipitation
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
7.2.1.1. Vaccine Production
7.2.1.2. Protein Replacement Therapies
7.2.1.3. Cancer Immunotherapies
Chapter 8. Market Segmentation 5: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User:
8.2.1.1. Hospitals and Clinics
8.2.1.2. Biotechnology & Pharmaceutical Companies
8.2.1.3. Contract Research Organizations
8.2.1.4. Academic & Research Institutions
Chapter 9. MRNA Synthesis Raw Materials Market Segmentation 4: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
9.1.2. North America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Method Type, 2021-2034
9.1.3. North America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.1.4. North America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.1.5. North America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe MRNA Synthesis Raw Materials Market revenue (US$ Million) by Product Type, 2021-2034
9.2.2. Europe MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Method Type, 2021-2034
9.2.3. Europe MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.2.4. Europe MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.2.5. Europe MRNA Synthesis Raw Materials Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific MRNA Synthesis Raw Materials Market revenue (US$ Million) by Product Type, 2021-2034
9.3.2. Asia Pacific MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Method Type, 2021-2034
9.3.3. Asia Pacific MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.3.4. Asia Pacific MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.3.5. Asia Pacific MRNA Synthesis Raw Materials Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America MRNA Synthesis Raw Materials Market revenue (US$ Million) by Product Type, 2021-2034
9.4.2. Latin America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Method Type, 2021-2034
9.4.3. Latin America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.4.4. Latin America MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.4.5. Latin America MRNA Synthesis Raw Materials Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa MRNA Synthesis Raw Materials Market revenue (US$ Million) by Product Type, (US$ Million)
9.5.2. Middle East & Africa MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Method Type, 2021-2034
9.5.3. Middle East & Africa MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.5.4. Middle East & Africa MRNA Synthesis Raw Materials Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.5.5. Middle East & Africa MRNA Synthesis Raw Materials Market revenue (US$ Million) by country, (US$ Million) 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Qiagen
10.2.2. Thermo Fisher Scientific
10.2.3. Promega Corporation
10.2.4. Agilent Technologies, Inc
10.2.5. Merck Kgaa
10.2.6. Miltenyi Biotec
10.2.7. Biobasic Inc
10.2.8. Takara Bio, Inc
10.2.9. New England Biolabs
10.2.10. Omega Bio-Tek, Inc
10.2.11. Norgen Biotek
10.2.12. Codex DNA, Inc.
10.2.13. Sartorius Stedim Biotech GmbH
10.2.14. Zymo Research
10.2.15. F. Hoffmann-La Roche Ag
10.2.16. Genaxxon Bioscience Gmbh
10.2.17. Biovision
10.2.18. Analytik Jena Ag
10.2.19. Bio-Rad Laboratories, Inc
10.2.20. AccuBioMed
10.2.21. NEBNext Poly(A) mRNA Magnetic Isolation Module
10.2.22. Arraystar, Inc
10.2.23. Fisher BioReagents
10.2.24. CD Bioparticles
10.2.25. United States Biological
10.2.26. Vdo Biotech
10.2.27. Bulldog Bio Inc
10.2.28. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.